CH618015A5 - - Google Patents

Download PDF

Info

Publication number
CH618015A5
CH618015A5 CH161277A CH161277A CH618015A5 CH 618015 A5 CH618015 A5 CH 618015A5 CH 161277 A CH161277 A CH 161277A CH 161277 A CH161277 A CH 161277A CH 618015 A5 CH618015 A5 CH 618015A5
Authority
CH
Switzerland
Prior art keywords
reagent
camp
cgmp
solution
reagents
Prior art date
Application number
CH161277A
Other languages
English (en)
French (fr)
Inventor
Omokazu Satoh
Junichi Takezawa
Akira Kuninaka
Miyuki Honma
Michio Ui
Original Assignee
Yamasa Shoyu Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Shoyu Kk filed Critical Yamasa Shoyu Kk
Publication of CH618015A5 publication Critical patent/CH618015A5/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CH161277A 1976-02-12 1977-02-10 CH618015A5 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51014665A JPS5825980B2 (ja) 1976-02-12 1976-02-12 サイクリックヌクレオチドの定量法

Publications (1)

Publication Number Publication Date
CH618015A5 true CH618015A5 (zh) 1980-06-30

Family

ID=11867499

Family Applications (1)

Application Number Title Priority Date Filing Date
CH161277A CH618015A5 (zh) 1976-02-12 1977-02-10

Country Status (7)

Country Link
US (1) US4115538A (zh)
JP (1) JPS5825980B2 (zh)
CA (1) CA1092022A (zh)
CH (1) CH618015A5 (zh)
DE (1) DE2705897C3 (zh)
FR (1) FR2341139A1 (zh)
GB (1) GB1527465A (zh)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4378344A (en) * 1979-09-28 1983-03-29 Ventrex Laboratories, Inc. Method and apparatus for performing multiple, simultaneous in vitro diagnostic tests using a solid phase system
US4433061A (en) * 1981-06-01 1984-02-21 American Hospital Supply Corporation Radioimmunoassay for cyclic nucleotides
JPS5811857A (ja) * 1981-07-15 1983-01-22 Yamasa Shoyu Co Ltd アデノシンの定量法
US5118607A (en) * 1989-10-23 1992-06-02 Hawaii Biotechnology Group, Inc. Non-aqueous solvent specific binding protein assays
CA2238283C (en) * 1997-05-30 2002-08-20 Cell Pathways, Inc. Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions
US7402400B2 (en) 2001-07-03 2008-07-22 Regents Of The University Of California Mammalian sweet taste receptors
US6794156B2 (en) 1999-05-10 2004-09-21 Applera Corporation Cell growth, induction and lysis in an antibody-coated microplate for use in an ELISA
US6686171B2 (en) * 1999-05-10 2004-02-03 Tropix, Inc. Competitive chemiluminescent assay for cyclic nucleotide monophosphates
TW201006846A (en) 2000-03-07 2010-02-16 Senomyx Inc T1R taste receptor and genes encidung same
TW201022287A (en) 2001-01-03 2010-06-16 Senomyx Inc T1R taste receptors and genes encoding same
US7883856B2 (en) 2001-04-05 2011-02-08 Senomyx Inc. Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulators
US7803982B2 (en) 2001-04-20 2010-09-28 The Mount Sinai School Of Medicine Of New York University T1R3 transgenic animals, cells and related methods
IL158488A0 (en) * 2001-04-20 2004-05-12 Sinai School Medicine Tir3 a novel taste receptor
US6809104B2 (en) * 2001-05-04 2004-10-26 Tularik Inc. Fused heterocyclic compounds
US20070135425A1 (en) * 2001-05-04 2007-06-14 Amgen Inc. Fused heterocyclic compounds
EP1412750B1 (en) 2001-06-26 2012-05-23 Senomyx, Inc. T1r2-t1r3 hetero-oligomeric sweet taste receptors and cell lines that express said receptors and use thereof for identification of sweet taste compounds
CA2463553A1 (en) * 2001-10-12 2003-04-17 The Regents Of The University Of California Gastrointestinal chemosensory receptors
KR20050103184A (ko) * 2002-11-06 2005-10-27 암젠 인코포레이션 융합된 헤테로사이클릭 화합물들
RU2006106920A (ru) 2003-08-06 2007-09-20 Синомикс Инк. (Us) Гетеро-олигомерные вкусовые рецепторы t1r, клеточные линии, которые экспрессируют указанные рецепторы и вкусовые соединения
US20050244810A1 (en) * 2003-09-29 2005-11-03 Egan Josephine M Taste signaling in gastrointestinal cells
ES2658859T3 (es) 2005-10-20 2018-03-12 Senomyx, Inc. Receptores del sabor dulce-umami y umami-dulce humanos quiméricos
KR101356892B1 (ko) * 2006-04-20 2014-01-28 지보당 에스아 미각자극물질을 동정하는 기능적인 방법
US20110097741A1 (en) * 2006-04-20 2011-04-28 Jay Patrick Slack Partial t1r2 nucleic acid sequence, receptor protein and its use in screening assays
EP2047254B1 (en) 2006-04-20 2015-10-28 Givaudan SA Method relating to sweetness enhancement
DK3235811T3 (en) 2006-04-21 2018-11-12 Senomyx Inc PROCEDURE FOR THE PREPARATION OF OXALAMIDS
US8039233B2 (en) * 2007-01-18 2011-10-18 Givaudan S.A. Nucleic acid sequences and their use in methods to identify umami modulatiors
JP5465656B2 (ja) 2007-03-30 2014-04-09 ジボダン エス エー 調節物質を同定するための方法
AU2008282805B2 (en) 2007-08-01 2014-05-01 Chugai Pharmaceutical Co., Ltd. Screening methods using G-protein coupled receptors and related compositions
CN101828111B (zh) 2007-08-21 2014-07-23 塞诺米克斯公司 人t2r苦味受体及其用途
WO2010037001A2 (en) 2008-09-26 2010-04-01 Immune Disease Institute, Inc. Selective oxidation of 5-methylcytosine by tet-family proteins
ES2558629T3 (es) * 2008-12-29 2016-02-05 Trevena, Inc. Efectores de beta-arrestina y composiciones y métodos de uso de los mismos
US8828953B2 (en) * 2009-04-20 2014-09-09 NaZura BioHealth, Inc. Chemosensory receptor ligand-based therapies
WO2010123930A2 (en) 2009-04-20 2010-10-28 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies
US9901551B2 (en) 2009-04-20 2018-02-27 Ambra Bioscience Llc Chemosensory receptor ligand-based therapies
SG184960A1 (en) 2010-05-07 2012-11-29 Givaudan Sa Methods to identify modulators
SG184962A1 (en) 2010-05-07 2012-11-29 Givaudan Sa Methods to identify modulators of tas2r4s receptors
MX2013004364A (es) 2010-10-19 2013-07-02 Elcelyx Therapeutics Inc Terapias a base de ligando del receptor quimiosensorial.
MX2013007884A (es) 2011-01-07 2013-09-13 Elcelyx Therapeutics Inc Terapias a base de ligando del receptor quimiosensorial.
SI2688403T1 (sl) 2011-03-23 2017-08-31 Trevena, Inc. Ligandi opioidnih receptorjev in metode uporabe in izdelave istega
US20130040317A1 (en) 2011-08-08 2013-02-14 The University Of North Carolina At Chapel Hill Cell lines comprising endogenous taste receptors and their uses
EP2742350B1 (en) 2011-08-08 2019-10-30 The Coca-Cola Company Cell lines comprising endogenous taste receptors and their uses
EA201491455A1 (ru) 2012-01-31 2015-01-30 Тревена, Инк. ЭФФЕКТОРЫ β-АРРЕСТИНА, КОМПОЗИЦИИ, ИХ СОДЕРЖАЩИЕ, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
WO2013158928A2 (en) 2012-04-18 2013-10-24 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies
WO2014124458A1 (en) 2013-02-11 2014-08-14 The Regents Of The University Of California Compositions and methods for treating neurodegenerative diseases
ES2797547T3 (es) 2013-03-15 2020-12-02 Applied Food Biotech Inc Receptores del sabor amargo felino y métodos.
AU2015213777A1 (en) 2014-02-07 2016-09-22 Trevena, Inc. Crystalline and amorphous forms of a beta-arrestin effector
CA2939219C (en) 2014-02-11 2023-02-28 Mitokinin Llc Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
US9611293B2 (en) 2014-05-19 2017-04-04 Trevena, Inc. Synthesis of beta-arrestin effectors
CN114773318A (zh) 2015-09-02 2022-07-22 特维娜有限公司 含有六元氮杂杂环的δ阿片受体调节化合物、其使用和制备方法
WO2017106306A1 (en) 2015-12-14 2017-06-22 Trevena, Inc. Methods of treating hyperalgesia
US20190178889A1 (en) * 2016-09-05 2019-06-13 BellBrook Labs High-throughput screening assay
BR112019016775A2 (pt) 2017-02-17 2020-03-31 Trevena, Inc. Compostos moduladores de receptor delta-opioide contendo aza-heterocíclico com 7 membros, métodos de uso e produção dos mesmos
AU2018221148B2 (en) 2017-02-17 2022-05-05 Trevena, Inc. 5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
EP3641545A4 (en) 2017-06-21 2021-02-24 Mitokinin, Inc. COMPOSITIONS AND METHODS USING THEM FOR THE TREATMENT OF NEURODEGENERATIVE AND MITOCHONDRIAL DISEASE
CN112858504A (zh) * 2021-01-08 2021-05-28 苏州国辰生物科技股份有限公司 一种液质联用测定生物体液样品中cGMP浓度的检测方法
WO2023154597A1 (en) 2022-02-11 2023-08-17 Firmenich Incorporated Cells expressing umami taste receptors and uses thereof

Also Published As

Publication number Publication date
FR2341139A1 (fr) 1977-09-09
FR2341139B1 (zh) 1979-10-05
JPS52117418A (en) 1977-10-01
CA1092022A (en) 1980-12-23
DE2705897C3 (de) 1980-02-28
DE2705897A1 (de) 1977-08-18
JPS5825980B2 (ja) 1983-05-31
DE2705897B2 (de) 1979-06-21
GB1527465A (en) 1978-10-04
US4115538A (en) 1978-09-19

Similar Documents

Publication Publication Date Title
CH618015A5 (zh)
Dixon Measurement of antibodies to insulin in serum
EP3394622B1 (fr) Diluant de reactifs
WO2015040319A1 (fr) Solution de dissociation de la vitamine d de sa protéine de liaison, procédé de détection associé et utilisation
Pacha A method for the fluorimetric determination of thioridazine (Mellaril®) or mesoridazine (Lidanil®) in Plasma
Samanidou et al. Development of a validated HPLC method for the determination of four penicillin antibiotics in pharmaceuticals and human biological fluids
EP0466565A1 (fr) Trousse pour le dosage spécifique de l'angiotensine II
FR2621128A1 (fr) Trousse et methode de dosage immunometrique applicables a des cellules entieres
FR2500009A1 (fr) Procede et systeme de necessaire experimental diagnostique pour determiner quantitativement la presence de la forme isoenzymatique mb de la creatine kinase
FR2678387A1 (fr) Procede de dosage immuno-enzymatique de la vitamine b12 et de preparation d'un echantillon pour ce dosage.
CH644455A5 (fr) Procede d'analyse quantitative des nucleotides cycliques et ensemble de reactifs pour la mise en oeuvre de ce procede.
FR2476320A1 (fr) Nouveau reactif immunologique pour la detection en tubes du facteur rhumatoide dans un echantillon biologique et procede de preparation de ce nouveau reactif
FR2763691A1 (fr) Procede ameliore d'analyse immunologique par polarisation de fluorescence
WO1999040442A1 (fr) Dosage des troponines sans interferences dues a l'heparine
EP2005181B1 (fr) Standard c4d / c4b pour cytometrie de flux quantitative du rejet humoral de transplantation
Murabayashi et al. Urinary dopamine, noradrenaline and adrenaline in type 2 diabetic patients with and without nephropathy
FR2537723A1 (fr) Procede et composition pour evaluer la reaction phagocytaire
FR2460482A1 (fr) Composition et procede de titrage de l'erythropoietine humaine
JP4163056B2 (ja) 血中インスリン濃度測定用添加剤組成物及びそれを含む採血管
FR2762602A1 (fr) Moyens pour la detection precoce de pathologies auto-immunes inflammatoires
JP3663781B2 (ja) 安定化方法
FR2466020A1 (fr) Reactif et methode pour la determination de l'aldolase du type contenu dans les muscles de l'homme
SU1719974A1 (ru) Способ определени тиопентала натри в крови
FR3014446A1 (fr) Stabilisation de la gdh en solution aqueuse
FR2510760A1 (fr) Dosage de folates par fixation competitive de proteines perfectionne et jeu de reactifs pour sa mise en oeuvre

Legal Events

Date Code Title Description
PL Patent ceased